Lung Cancer Screening and Prevention Act of 2025

119 HR 1406 IH: Lung Cancer Screening and Prevention Act of 2025 U.S. House of Representatives 2025-02-18 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. I119th CONGRESS1st SessionH. R. 1406IN THE HOUSE OF REPRESENTATIVESFebruary 18, 2025Mr. Buchanan (for himself, Mr. Kennedy of New York, Mr. Griffith, Mr. LaHood, Mr. Soto, and Ms. Wasserman Schultz) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concernedA BILLTo amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program.

1.Short titleThis Act may be cited as the Lung Cancer Screening and Prevention Act of 2025.

2.Authority to expand coverage of tests for lung cancer screening under the medicare program (a)In generalSection 1834(n) of the Social Security Act (42 U.S.C. 1395m(n)) is amended— (1)by redesignating subparagraphs (A) and (B) of paragraph (1) as clauses (i) and (ii), respectively, with appropriate indentation; (2)by redesignating paragraphs (1) and (2) as subparagraphs (A) and (B), respectively, with appropriate indentation; (3)by striking Notwithstanding any other provision of this title and inserting: (1)In generalNotwithstanding any other provision of this title and subject to paragraph (2); and (4)by adding at the end the following new paragraph: (2)Authority to cover new lung cancer screening tests as preventive services (A)In generalNotwithstanding paragraph (1), in addition to preventive services consisting of screening tests for the early detection of lung cancer covered under this part pursuant to national coverage determination 210.14, the Secretary may provide for coverage under this part of other lung cancer screening tests that are cleared or approved by the Food and Drug Administration as preventive services when furnished to appropriate individuals (as determined by the Secretary), with such frequency and payment limits as the Secretary determines appropriate in consultation with appropriate organizations. (B)Use of national coverage determination process (i)In generalCoverage of other lung cancer screening tests under subparagraph (A) shall be determined using the process for making national coverage determinations (as defined in section 1869(f)(1)(B)), except that there shall be no requirement for a determination under section 1861(ddd)(3)(B) with respect to such test under such process. (ii)Rule of constructionNothing in clause (i) shall be construed as preventing the Secretary from considering recommendations made by entities with expertise in preventive services, including entities convened by the Secretary or the Director of the Agency for Healthcare Research and Quality, with respect to other lung cancer screening tests described in subparagraph (A).. (b)Effective dateThe amendments made by subsection (a) shall take effect on the date of the enactment of this Act, and apply with respect to coverage of preventive services under Part B of title XVIII of the Social Security Act (42 U.S.C. 1395j et seq.) on or after such date.